Citation Impact
Citing Papers
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
2012
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Pharmacokinetic/Pharmacodynamic Profile of Voriconazole
2006
Nano-based smart pesticide formulations: Emerging opportunities for agriculture
2018 Standout
Visible light photoredox catalysis: applications in organic synthesis
2010 Standout
Clinical pharmacokinetics of voriconazole
2006
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
2011
Rethinking amide bond synthesis
2011 StandoutNature
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
2016 Standout
Bioactivation of herbal constituents: simple alerts in the complex system
2011
Maraviroc
2007
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Fluorine in Medicinal Chemistry
2015
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Visible light photocatalysis as a greener approach to photochemical synthesis
2010 Standout
Methods for in vitro evaluating antimicrobial activity: A review
2015 Standout
Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
2011
Daylight Photodynamic Therapy for Actinic Keratoses
2018
Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
2011
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Effects of Dietary Phytoestrogens in Vivo and in Vitro in Rainbow Trout and Siberian Sturgeon: Interests and Limits of the in Vitro Studies of Interspecies Differences
2002
The Future of Peptide‐based Drugs
2012 Standout
Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats
2007 StandoutNobel
tBuLi‐Mediated One‐Pot Direct Highly Selective Cross‐Coupling of Two Distinct Aryl Bromides
2015 StandoutNobel
The ChEMBL database in 2017
2016 Standout
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
2010
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Steady-state pharmacokinetics and metabolism of voriconazole in patients
2013
The road map to oral bioavailability: an industrial perspective
2006
Synthetic therapeutic peptides: science and market
2009
Establishment and Characterization of the Transformants Stably-Expressing MDR1 Derived from Various Animal Species in LLC-PK1
2006
An analysis of the attrition of drug candidates from four major pharmaceutical companies
2015 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Fluorine in medicinal chemistry
2007 Standout
Contribution of Organofluorine Compounds to Pharmaceuticals
2020 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods
2006
Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery
2013 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Expanding the utilization of sustainable plant products in aquafeeds: a review
2007 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
2011 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Physicologically Based Toxicokinetic Models of Tebuconazole and Application in Human Risk Assessment
2016
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
2012
AspergillusInfections in Transplant Recipients
2005
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity
2010 StandoutNobel
Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
2008
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Pharmacogenomics of the Triazole Antifungal Agent Voriconazole
2011
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
2009 Standout
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Assessment of Efficacy of Antifungals against Aspergillus fumigatus: Value of Real-Time Bioluminescence Imaging
2013
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Fluorine in health care: Organofluorine containing blockbuster drugs
2010 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
The merger of transition metal and photocatalysis
2017 Standout
Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle
2009
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of Pierre Comby being referenced
SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV
2005
NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS
2004
Preclinical safety profile of sildenafil
2004
Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation
2016
In vitro toxicity of zamifenacin (UK-76,654) and metabolites in primary hepatocyte cultures
1998
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
2003
Characterisation of the vascular and inflammatory lesions induced by the PDE4 inhibitor CI-1044 in the dog
2008